These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6125097)

  • 1. Clinical pharmacology of adrenergic-adrenoreceptor-blocking drugs.
    Louis WJ; Taylor H; McNeil JJ; Jarrott B; Rand MJ
    Am Heart J; 1982 Aug; 104(2 Pt 2):407-12. PubMed ID: 6125097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
    Levy JV
    Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.
    Prichard BN
    Br J Clin Pharmacol; 1978 May; 5(5):379-99. PubMed ID: 26370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
    Harry JD
    Bibl Cardiol; 1976; (35):172-82. PubMed ID: 10882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of adrenergic-blocking drugs.
    Louis WJ; Rand MJ; McNeil JJ; Drummer O; Jarrott B
    Cardiology; 1979; 64 Suppl 1():96-104. PubMed ID: 42490
    [No Abstract]   [Full Text] [Related]  

  • 7. The additional properties of beta adrenoceptor blocking drugs.
    Prichard BN; Tomlinson B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S1-15. PubMed ID: 2427833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.
    Lund-Johansen P
    Eur Heart J; 1983 Jul; 4 Suppl D():1-12. PubMed ID: 6137366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic trials of pindolol in hypertension: comparison and combination with other drugs.
    Fanchamps A
    Am Heart J; 1982 Aug; 104(2 Pt 2):388-406. PubMed ID: 6125096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
    McNeil JJ; Louis WJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenergic receptor blocking drugs in angina pectoris.
    Prichard BN
    Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of once-daily bopindolol, pindolol and atenolol in essential hypertension.
    Schiess W; Welzel D; Gugler R
    Eur J Clin Pharmacol; 1984; 27(5):529-34. PubMed ID: 6151506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum creatine phosphokinase levels during treatment with beta-adrenoreceptor blocking agents.
    Saruta T; Suzuki H; Kawamura M; Itoh H
    J Cardiovasc Pharmacol; 1985; 7(4):805-8. PubMed ID: 2410725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
    Frishman WH; Furberg CD; Friedewald WT
    Curr Probl Cardiol; 1984 Jun; 9(3):1-50. PubMed ID: 6146495
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antihypertensive action of several beta-adrenoreceptor-blocking drugs.
    Waal-Manning HJ
    N Z Med J; 1976 Apr; 83(561):223-6. PubMed ID: 8748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension and beta-blockers. Are they all the same?
    Raftery EB; Carrageta MO
    Int J Cardiol; 1985 Apr; 7(4):337-46. PubMed ID: 2859251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.